Table 2.
Intragroup comparison of clinical parameters from baseline and 8 weeks after treatment
Groups | Clinical parameters | Time interval | n | Mean±SD | Mean difference | 95% CI | t | df | P | |
---|---|---|---|---|---|---|---|---|---|---|
| ||||||||||
Lower | Upper | |||||||||
A1 | PI | Baseline | 16 | 1.73±0.45 | 1.04 | 0.75 | 1.33 | 7.73 | 15.0 | <0.001* |
8 weeks | 16 | 0.69±0.21 | ||||||||
BI | Baseline | 16 | 1.90±0.63 | 1.46 | 1.142 | 1.77 | 9.86 | 15.0 | <0.001* | |
8 weeks | 16 | 0.44±0.17 | ||||||||
PD | Baseline | 16 | 6.05±0.63 | 3.19 | 2.79 | 3.54 | 18.1 | 15.0 | <0.001* | |
8 weeks | 16 | 2.88±0.41 | ||||||||
CAL | Baseline | 16 | 6.06±0.66 | 2.18 | 2.79 | 3.56 | 17.7 | 15.0 | <0.001* | |
8 weeks | 16 | 2.88±0.41 | ||||||||
A2 | PI | Baseline | 14 | 1.71±0.51 | 1.11 | 0.815 | 1.41 | 8.04 | 13.0 | <0.001* |
8 weeks | 14 | 0.69±0.21 | ||||||||
BI | Baseline | 14 | 2.29±0.42 | 1.17 | 0.908 | 1.44 | 9.59 | 13.0 | <0.001* | |
8 weeks | 14 | 1.12±0.48 | ||||||||
PD | Baseline | 14 | 5.98±0.59 | 2.99 | 2.57 | 3.54 | 15.3 | 13.0 | <0.001* | |
8 weeks | 14 | 2.99±0.43 | ||||||||
CAL | Baseline | 14 | 2.99±0.43 | 3.03 | 2.58 | 3.49 | 14.4 | 13.0 | <0.001* | |
8 weeks | 14 | 2.99±0.43 | ||||||||
B1 | PI | Baseline | 14 | 2.00±0.66 | 1.62 | 1.26 | 1.97 | 9.92 | 13.0 | <0.001* |
8 weeks | 14 | 0.38±0.14 | ||||||||
BI | Baseline | 14 | 1.96±0.62 | 1.54 | 1.53 | 1.92 | 8.66 | 13.0 | <0.001* | |
8 weeks | 14 | 0.43±0.17 | ||||||||
PD | Baseline | 14 | 5.93±0.97 | 2.93 | 2.50 | 3.52 | 14.9 | 13.0 | <0.001* | |
8 weeks | 14 | 3.00±0.48 | ||||||||
CAL | Baseline | 14 | 6.15±0.94 | 3.03 | 2.68 | 3.38 | 18.9 | 13.0 | <0.001* | |
8 weeks | 14 | 3.12±0.59 | ||||||||
B2 | PI | Baseline | 16 | 2.14±0.57 | 1.83 | 1.55 | 2.10 | 14.30 | 15.0 | <0.001* |
8 weeks | 16 | 0.31±0.14 | ||||||||
BI | Baseline | 16 | 1.84±0.55 | 1.39 | 1.086 | 1.69 | 9.84 | 15.0 | <0.001* | |
8 weeks | 16 | 0.45±0.12 | ||||||||
PD | Baseline | 16 | 5.87±0.94 | 3.01 | 2.50 | 3.52 | 12.6 | 15.0 | <0.001* | |
8 weeks | 16 | 2.86±0.44 | ||||||||
CAL | Baseline | 16 | 5.97±1.00 | 3.04 | 2.55 | 3.53 | 13.3 | 15.0 | <0.001* | |
8 weeks | 16 | 2.93±0.49 |
*Paired t-test, value of P is considered statistically significant P<0.05. n – Number of participants; SD – Standard deviation; t – t statistic value; df – Degrees of freedom; P – Probability; T2DM – Type 2 diabetes mellitus; A1 – Periodontitis participants receiving scaling and root planing alone; A2 – Periodontitis participants receiving scaling and root planing with adjunctive to low-level laser therapy; B1 – Periodontitis participants with T2DM receiving scaling and root planing alone; B2 – Periodontitis participants with T2DM receiving scaling and root planing with adjunctive low level laser therapy; PI – Plaque index; BI – Bleeding index; PD – Probing depth; CAL – Clinical attachment level; CI – Confidence interval